SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.

In patients with acute heart failure, it is unclear how body mass index affects clinical outcomes following acute myocardial infarction.

Composite of coronary heart disease death and non-fatal myocardial infarction was less frequent in the CCTA group compared to ...

Research has linked higher levels of air pollution to the risk of acute myocardial infarctions, or heart attacks. How these ...

In recent years, the rate of cardiovascular mortality following high-risk myocardial infarction has significantly declined.

For over two decades, a ‘treatment-risk paradox’ has been described in older adults with cardiovascular disease, with ...

The following is a summary of "Impact of sodium-glucose cotransporter‐2 inhibitors in patients with recent versus previous ...

Among stroke survivors, the risk of developing dementia after stroke is significantly high, highlighting the need for targeted prevention strategies.

The following is a summary of "Low-dose dobutamine stress myocardial contrast echocardiography for evaluating myocardial ...

A new review published in Genes & Diseases highlights macrophage-targeted therapy as a promising frontier in cardiac regeneration and myocardial repair.

Medtronic (NYSE: MDT) announced results from a registry highlighting the effectiveness of the Prevail drug-coated balloon ...

A new clinical trial finds no cardiovascular benefit from high-dose multivitamins, with or without chelation therapy, in ...